LYC Healthcare, a Singapore-based operator of medical clinics and an orthopedic surgery center, has raised the proposed size of its upcoming initial public offering on Tuesday. The company now intends to offer 6.3 million shares at a proposed price of $4 per share, aiming to raise $25 million.
This adjustment follows an earlier filing where the company planned to issue 3 million shares within a price range of $4 to $6 each. Based on the revised offering size, LYC Healthcare's expected fundraising proceeds have increased by 67% from previous estimates, translating to a market capitalization of approximately $137 million. The company is slated to debut on the Nasdaq, though a ticker symbol has not yet been determined.
Founded in 2017, LYC Healthcare operates as a multidisciplinary specialty healthcare provider in Singapore, delivering integrated musculoskeletal medical services through two operating subsidiaries, five medical clinics, and in-house advanced imaging facilities. The practice employs four physicians, including two specialists, who perform computer-navigated total hip and knee replacement surgeries alongside minimally invasive and interventional procedures. The company also provides MRI, CT, X-ray, bone mineral density (BMD), and ultrasound imaging services, complemented by on-site physiotherapy through a three-year partnership.
LYC Healthcare caters to patients suffering from degenerative joint diseases, spinal conditions, sports injuries, metabolic disorders, and osteoporosis, offering a comprehensive spectrum of care that spans health screenings, diagnostic imaging, treatment, and rehabilitation. Financial data reveals that the company generated $14 million in revenue for the 12-month period ending March 31, 2025.
Comments